Imidocarb
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101663This classification denotes an antiprotozoal agent with the molecular formula C19H20N6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8USS3K0VDH, chemically known as 3,3-di-2-imidazolin-2-ylcarbanilide dihydrochloride but generally known as imidocarb, which bears US NIH Compound Identifier 21389. European Medicines Agency schedules Imidocarb in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08146MIG. The term IMIDOCARB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). IMIDOCARB is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule imidocarb under HS 29332990 and SITC 51573. As of Q4 2014, IMIDOCARB remains the US FDA Preferred Term for this commodity. Imidocarb bears US NLM identifiers UMLS ID C0020928 and NCI Concept Code C83790. SMILES: O=C(NC1CC(C2=NCCN2)CCC1)NC1CC(C2=NCCN2)CCC1.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.